Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.53 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | MME | P08473 | 1/20 | 0.37 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.33 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA3 | P07451 | 1/20 | 0.32 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8629351 | 0.85 | ALDH1A1 (0.42) | ALDH1A1PKMKMT2AATMSLC1A2 | |
| SCHEMBL2332165 | 0.84 | ALDH1A1 (0.56) | ALDH1A1PKMKMT2AATMMME | |
| SCHEMBL604671 | 0.84 | ALDH1A1 (0.56) | ALDH1A1PKMKMT2AATMMME | |
| SCHEMBL2913712 | 0.83 | ALDH1A1 (0.40) | ALDH1A1PKMKMT2AATMSLC1A2 | |
| Propionic Acid SCHEMBL7866660 | 0.81 | ALDH1A1 (0.50) | ALDH1A1PKMKMT2AATMMME | |
| Ethylene SCHEMBL29141463 | 0.81 | ALDH1A1 (0.53) | ALDH1A1PKMKMT2AATMMME | |
| SCHEMBL30302184 | 0.81 | ALDH1A1 (0.53) | ALDH1A1PKMKMT2AATMMME | |
| SCHEMBL2513933 | 0.81 | ALDH1A1 (0.53) | ALDH1A1PKMKMT2AATMMME | |
| SCHEMBL2516387 | 0.81 | ALDH1A1 (0.53) | ALDH1A1PKMKMT2AATMMME | |
| Ethylene SCHEMBL8387032 | 0.81 | ALDH1A1 (0.53) | ALDH1A1PKMKMT2AATMMME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101052617-B | Process for the preparation of alkyl 5-(dicarboximido)levulinate and alkyl 4-oxo-pentenoate | BIOSYNTH AB | 2010-11-03 | — | — | CN | claimed |
| CN-101052617-A | Process for the preparation of alkyl 5-(dicarboximido)levulinate and alkyl 4-oxo-pentenoate | BIOSYNTH AB (SE) | 2007-10-10 | — | — | CN | claimed |
| US-20220289809-A1 | USE OF RELAXIN TO TREAT ATRIAL FIBRILLATION | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2022-09-15 | — | — | US | disclosed |
| US-10759846-B2 | Middle east respiratory syndrome coronavirus immunogens, antibodies, and their use | THE U.S.A., AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2020-09-01 | — | — | US | disclosed |
| US-20200087371-A1 | USE OF RELAXIN TO TREAT ATRIAL FIBRILLATION | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION | 2020-03-19 | — | — | US | disclosed |
| US-20190256579-A1 | MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS IMMUNOGENS, ANTIBODIES, AND THEIR USE | THE U.S.A., AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2019-08-22 | — | — | US | disclosed |
| US-10301377-B2 | Middle east respiratory syndrome coronavirus immunogens, antibodies, and their use | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2019-05-28 | — | — | US | disclosed |
| US-20180244756-A1 | MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS IMMUNOGENS, ANTIBODIES, AND THEIR USE | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES (US) | 2018-08-30 | — | — | US | disclosed |
| EP-3261665-A1 | MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS IMMUNOGENS, ANTIBODIES, AND THEIR USE | The United States of America, as represented by The Secretary, Department of Health and Human Services (US) | 2018-01-03 | — | — | EP | disclosed |
| US-20170342120-A1 | USE OF RELAXIN TO TREAT ATRIAL FIBRILLATION | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION | 2017-11-30 | — | — | US | disclosed |
| WO-2016138160-A1 | MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS IMMUNOGENS, ANTIBODIES, AND THEIR USE | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2016-09-01 | — | — | WO | disclosed |
| EP-1812474-A2 | MULTI-DOMAIN AMPHIPATHIC HELICAL PEPTIDES AND METHODS OF THEIR USE | The United States of America as represented by The Secretary, Department of Health and Human Services National Institutes of Health (US) | 2007-08-01 | — | — | EP | disclosed |
| EP-1765394-A1 | METHODS FOR PREPARING IMMUNOGENIC CONJUGATES | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, represented by THE DEPARTMENT OF HEALTH & HUMAN SERVICES (US) | 2007-03-28 | — | — | EP | disclosed |
| WO-2007008904-A2 | TARGETING POLY-GAMMA-GLUTAMIC ACID TO TREAT STAPHYLOCOCCUS EPIDERMIDIS AND RELATED INFECTIONS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2007-01-18 | — | — | WO | disclosed |
| US-20060134143-A1 | Poly-gamma-glutamic conjugates for eliciting immune responses directed against bacilli | GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, THE | 2006-06-22 | — | — | US | disclosed |
| WO-2006044596-A2 | MULTI-DOMAIN AMPHIPATHIC HELICAL PEPTIDES AND METHODS OF THEIR USE | THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2006-04-27 | — | — | WO | disclosed |
| EP-1633778-A1 | POLY-GAMMA-GLUTAMIC ACID CONJUGATES FOR ELICITING IMMUNE RESPONSES DIRECTED AGAINST BACILLI | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2006-03-15 | — | — | EP | disclosed |
| WO-2005117965-A1 | METHODS FOR PREPARING IMMUNOGENIC CONJUGATES | THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2005-12-15 | — | — | WO | disclosed |
| US-20050271675-A1 | Methods for preparing immunogenic conjugates | THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF | 2005-12-08 | — | — | US | disclosed |
| WO-2005000884-A1 | POLY-GAMMA-GLUTAMIC CONJUGATES FOR ELICITING IMMUNE RESPONSES DIRECTED AGAINST BACILLI | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2005-01-06 | — | — | WO | disclosed |